SCHEMBL2554320

SCHEMBL2554320

Cc1cnn(-c2nc(N)c(C3CC3)c(N)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TDO2 P48775 1/20 0.41
EGLN1 Q9GZT9 1/20 0.38
PDE10A Q9Y233 4/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 1/20 0.34
IDH1 O75874 1/20 0.33
IDH2 P48735 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
ADORA2A P29274 3/20 0.32
CYP46A1 Q9Y6A2 1/20 0.31
NOS1 P29475 1/20 0.31
SCD O00767 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2556805 0.94 EGLN1 (0.44) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL14672678 0.74 ADORA2A (0.62) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL2547017 0.73 ADORA2A (0.53) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL2576944 0.72 KMT2A (0.45) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL14717394 0.72 ADORA2A (0.63) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL14672677 0.72 ADORA2A (0.63) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL2547620 0.71 ADORA2A (0.56) MAPTMAPK1NPSR1L3MBTL1PDE10A
SCHEMBL2551256 0.70 ADORA2A (0.47) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL2554675 0.70 ADORA2A (0.47) KDM4EMAPTMAPK1NPSR1L3MBTL1
SCHEMBL2546203 0.70 ADORA2A (0.60) KDM4EMAPTMAPK1NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011121418-A1 4 - AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2A RECEPTOR ANTAGONISTS PALOBIOFARMA, S.L. (ES) 2011-10-06 WO disclosed